172 related articles for article (PubMed ID: 34440250)
1. Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo.
Bazaz S; Lehto T; Tops R; Gissberg O; Gupta D; Bestas B; Bost J; Wiklander OPB; Sork H; Zaghloul EM; Mamand DR; Hällbrink M; Sillard R; Saher O; Ezzat K; Smith CIE; Andaloussi SE; Lehto T
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440250
[TBL] [Abstract][Full Text] [Related]
2. Use of cell-penetrating-peptides in oligonucleotide splice switching therapy.
El Andaloussi SA; Hammond SM; Mäger I; Wood MJ
Curr Gene Ther; 2012 Jun; 12(3):161-78. PubMed ID: 22533378
[TBL] [Abstract][Full Text] [Related]
3. Delivery of therapeutic oligonucleotides with cell penetrating peptides.
Boisguérin P; Deshayes S; Gait MJ; O'Donovan L; Godfrey C; Betts CA; Wood MJ; Lebleu B
Adv Drug Deliv Rev; 2015 Jun; 87():52-67. PubMed ID: 25747758
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice switching morpholino oligonucleotide in spinal muscular atrophy patient-derived fibroblasts.
Tajik-Ahmadabad B; Polyzos A; Separovic F; Shabanpoor F
Int J Pharm; 2017 Oct; 532(1):21-28. PubMed ID: 28864392
[TBL] [Abstract][Full Text] [Related]
5. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
[TBL] [Abstract][Full Text] [Related]
6. A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides.
Trabulo S; Resina S; Simões S; Lebleu B; Pedroso de Lima MC
J Control Release; 2010 Jul; 145(2):149-58. PubMed ID: 20362021
[TBL] [Abstract][Full Text] [Related]
7. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
8. Delivery of Splice Switching Oligonucleotides by Amphiphilic Chitosan-Based Nanoparticles.
Moreno PM; Santos JC; Gomes CP; Varela-Moreira A; Costa A; Leiro V; Mansur H; Pêgo AP
Mol Pharm; 2016 Feb; 13(2):344-56. PubMed ID: 26702499
[TBL] [Abstract][Full Text] [Related]
9. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
10. Peptides for nucleic acid delivery.
Lehto T; Ezzat K; Wood MJA; El Andaloussi S
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
[TBL] [Abstract][Full Text] [Related]
11. Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids.
Shimo T; Nakatsuji Y; Tachibana K; Obika S
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805378
[TBL] [Abstract][Full Text] [Related]
12. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
13. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
14. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy.
Hammond SM; Abendroth F; Gait MJ; Wood MJA
Methods Mol Biol; 2019; 2036():221-236. PubMed ID: 31410800
[TBL] [Abstract][Full Text] [Related]
16. CLIP6-PNA-Peptide Conjugates: Non-Endosomal Delivery of Splice Switching Oligonucleotides.
Soudah T; Mogilevsky M; Karni R; Yavin E
Bioconjug Chem; 2017 Dec; 28(12):3036-3042. PubMed ID: 29211451
[TBL] [Abstract][Full Text] [Related]
17. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
18. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
19. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate.
Guterstam P; Madani F; Hirose H; Takeuchi T; Futaki S; El Andaloussi S; Gräslund A; Langel U
Biochim Biophys Acta; 2009 Dec; 1788(12):2509-17. PubMed ID: 19796627
[TBL] [Abstract][Full Text] [Related]
20. Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides.
Lehto T; Vasconcelos L; Margus H; Figueroa R; Pooga M; Hällbrink M; Langel Ü
Bioconjug Chem; 2017 Mar; 28(3):782-792. PubMed ID: 28209057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
